These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 16313323)
1. Splenectomy and preemptive interferon therapy for hepatitis C patients after living-donor liver transplantation. Kishi Y; Sugawara Y; Akamatsu N; Kaneko J; Tamura S; Kokudo N; Makuuchi M Clin Transplant; 2005 Dec; 19(6):769-72. PubMed ID: 16313323 [TBL] [Abstract][Full Text] [Related]
2. Living donor liver transplantation for end-stage hepatitis C. Sugawara Y; Kaneko J; Akamatsu N; Kishi Y; Hata S; Kokudo N; Makuuchi M Transplant Proc; 2004 Jun; 36(5):1481-2. PubMed ID: 15251363 [TBL] [Abstract][Full Text] [Related]
3. Review article: the treatment of hepatitis C virus recurrence after liver transplantation. Arjal RR; Burton JR; Villamil F; Rosen HR Aliment Pharmacol Ther; 2007 Jul; 26(2):127-40. PubMed ID: 17593060 [TBL] [Abstract][Full Text] [Related]
4. Antiviral therapy for hepatitis C virus recurrence following liver transplantation: long-term results from a single center experience. Burra P; Targhetta S; Pevere S; Boninsegna S; Guido M; Canova D; Brolese A; Masier A; D'Aloiso C; Germani G; Tomat S; Fagiuoli S Transplant Proc; 2006 May; 38(4):1127-30. PubMed ID: 16757285 [TBL] [Abstract][Full Text] [Related]
5. [The course of hepatitis C infection after liver transplantation]. Ołdakowska-Jedynak U; Paczek L Pol Merkur Lekarski; 2005 Aug; 19(110):220-4. PubMed ID: 16245439 [TBL] [Abstract][Full Text] [Related]
6. Intra portal donor specific antigen transfusion might prevent re-infection of hepatitis C virus after living related liver transplantation in hepatitis C hepatic cirrhosis. Sato Y; Oya H; Yamamoto S; Kobayashi T; Watanabe T; Kokai H; Yamagiwa S; Hatakeyama K Hepatogastroenterology; 2009; 56(89):205-7. PubMed ID: 19453058 [TBL] [Abstract][Full Text] [Related]
7. Viral hepatitis and liver transplantation. Sharma P; Lok A Semin Liver Dis; 2006 Aug; 26(3):285-97. PubMed ID: 16850378 [TBL] [Abstract][Full Text] [Related]
8. Chronic hepatitis C virus infection in renal transplant: treatment and outcome. Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715 [TBL] [Abstract][Full Text] [Related]
10. Impact of graft size on postoperative thrombocytopenia in living donor liver transplant. Marubashi S; Dono K; Miyamoto A; Takeda Y; Nagano H; Umeshita K; Monden M Arch Surg; 2007 Nov; 142(11):1054-8. PubMed ID: 18025333 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C therapy before and after liver transplantation. Terrault NA Liver Transpl; 2008 Oct; 14 Suppl 2():S58-66. PubMed ID: 18825697 [TBL] [Abstract][Full Text] [Related]
12. Impact of double-filtration plasmapheresis in combination with interferon and ribavirin in living donor liver transplant recipients with hepatitis C. Taniguchi M; Furukawa H; Shimamura T; Suzuki T; Yamashita K; Ota M; Todo S Transplantation; 2006 Jun; 81(12):1747-9. PubMed ID: 16794544 [TBL] [Abstract][Full Text] [Related]
13. Recurrence of hepatitis C after liver transplantation. Friman S Transplant Proc; 2005 Oct; 37(8):3311-2. PubMed ID: 16298582 [TBL] [Abstract][Full Text] [Related]
14. Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C. Fernández I; Ulloa E; Colina F; Abradelo M; Jiménez C; Gimeno A; Meneu JC; Lumbreras C; Solís-Herruzo JA; Moreno E Liver Transpl; 2009 Aug; 15(8):948-55. PubMed ID: 19642125 [TBL] [Abstract][Full Text] [Related]
15. Relapse response to interferon and ribavirin in liver transplant recipient with hepatitis C recurrence. Coccoli P; Cordone G; Bruno M; Parrilli G Transplant Proc; 2005 Dec; 37(10):4406-7. PubMed ID: 16387132 [TBL] [Abstract][Full Text] [Related]
16. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12. Raziorrouh B; Jung MC; Schirren CA; Loehe F; Thiel M; Nitschko H; Diepolder H; Ulsenheimer A; Heeg M; Zachoval R; Gruener NH Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):778-83. PubMed ID: 18617783 [TBL] [Abstract][Full Text] [Related]
18. Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection. Kuo A; Tan V; Lan B; Khalili M; Feng S; Roberts JP; Terrault NA Liver Transpl; 2008 Oct; 14(10):1491-7. PubMed ID: 18825708 [TBL] [Abstract][Full Text] [Related]
19. Worse recent efficacy of antiviral therapy in liver transplant recipients with recurrent hepatitis C: impact of donor age and baseline cirrhosis. Berenguer M; Aguilera V; Prieto M; Ortiz C; Rodríguez M; Gentili F; Risalde B; Rubin A; Cañada R; Palau A; Rayón JM Liver Transpl; 2009 Jul; 15(7):738-46. PubMed ID: 19562707 [TBL] [Abstract][Full Text] [Related]
20. Clinical features of biochemical cholestasis in patients with recurrent hepatitis C after living-donor liver transplantation. Ueda Y; Takada Y; Marusawa H; Haga H; Sato T; Tanaka Y; Egawa H; Uemoto S; Chiba T J Viral Hepat; 2010 Jul; 17(7):481-7. PubMed ID: 19804502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]